Director, HEOR Strategy - Oncology

About the role

The Oncology HEOR Strategy team, within the MHI Value & Evidence function, leads the creation and communication of transformative evidence to shape healthcare decision-making and make a remarkable impact for patients.

Responsibilities

• Accountable for engagement and co-creation of holistic value evidence strategy with V&E pillars and cross-functional partners for Oncology disease areas/assets/brands, including co-creation of PCM deliverables, MHI Worldwide Scientific Plan, and Value & Evidence Plans (VEP) and ensuring timely relevance to disease area strategy, product development, competitive landscape, and the marketplace.
• Directs the design, conduct, and analysis of projects within each product area strategy across multiple programs, in partnership with V&E Centers of Excellence (PCOR, VAC, RWE, EPE, MPS) and is accountable for project execution, budget and meeting/exceeding ethical, scientific, regulatory, commercial, and quality requirements.
• HSL interacts/engages with cross-functional leaders for CLL disease area. Effectively communicates findings to internal leadership (Executive Leadership, Area VPs, GMs etc.) and external (e.g. HTAs/Payers, patient advocacy groups and KOLs etc.).
• In the post-marketing setting, this position is responsible for developing and executing V&E product life-cycle and labeling strategies. Responsible for integrating the expressed needs for value demonstration from customers (physicians, patients, payers, policy-makers), the direction of the commercial organization in product marketing and the realities of the science surrounding a product in developing strategies.
• Assumes full strategic V&E support of commercialization activities including the facilitation of obtaining and maintaining market access and growing/defending the market.
• Accountable for end-to-end delivery of V&E book of work under their remit, from strategy development to content pull through.
• Accountable for ensuring strong partnership with MHI, IMAP and all relevant V&E pillars to ensure a holistic and comprehensive voice to accelerate global patient access, in cross-functional meetings.
• PARTNERS WITH HEME-ONCOLOGY HEOR STRATEGY TEAM LEAD TO SHAPE CLL ONCOLOGY PATIENT ACCESS POLICY ENVIRONMENT, INCLUDING SUCCESSFULLY ENGAGING AND COLLABORATING HTA/PAYERS, CLINICAL PRACTICE GUIDELINE ORGANIZATIONS AND US ONCOLOGY PATHWAY STAKEHOLDERS.
• PARTNERS WITH HEME-ONCOLOGY HEOR STRATEGY TEAM LEAD TO ESTABLISH EXTERNAL ALLIANCES TO DRIVE HEME-ONCOLOGY PAYER/PATHWAY CENTRIC FIT-FOR-PURPOSE EVIDENCE GENERATION IN SUPPORT OF PRE- AND POST-LAUNCH ASSETS.
• DEVELOPS AND MAINTAINS CLL ONCOLOGY RESEARCH PARTNERSHIPS WITH ACADEMIC AND COMMUNITY ONCOLOGY CENTERS AND PATHWAYS TO DEMONSTRATE THE CLINICAL, ECONOMIC, HUMANISTIC AND SOCIETAL VALUE OF INNOVATIVE ABBVIE THERAPIES.

Requirements

• Advanced degree required: MSc, MPH, or MBA with 10+ years of relevant experience; or PharmD/PhD with 7+ years in HEOR, market access, or a related research-focused field.
• Deep expertise in HEOR methods including health economic modeling, patient-reported outcomes, statistics, and real-world evidence, with strong experience in registry and observational study design, execution, analysis, and interpretation.
• Proven oncology HEOR and market access experience across pipeline, launch, in-line, and lifecycle management.
• Strong understanding of oncology health technology development and commercialization, including drugs and diagnostic devices.
• Highly effective influencer in matrixed environments, with the ability to align medical, clinical, access, affiliate, and commercial partners without direct authority.
• Track record of success in HTA/value assessment and engagement with key bodies such as NCCN, ESMO-MCBS, NICE, IQWiG, CADTH, MSAC, ICER, and similar organizations.
• Experience partnering with IDNs, GPOs, and collaborative groups to support external research initiatives.
• Thrives in fast-paced, high-accountability environments and can independently lead complex HEOR initiatives, including SLRs, ITCs, NMAs, PRO/PED studies, RWE, DCEs, economic models, and non-interventional studies.
• Strong strategic judgment with the ability to assess value, prioritize against business needs, and make decisions quickly and simply.
• Excellent interpersonal, oral, and written communication skills in English, with a track record of building strong internal and external partnerships.
• Strong project management skills, including contracting, budgeting, and vendor management, with the ability to juggle multiple complex priorities and shifting deadlines.
• Highly organized, proactive, and adaptable, with a bias for action and comfort operating in changing, fast-moving environments.

Qualifications

• People leadership experience preferred, with demonstrated ability to engage stakeholders and deliver results through others.

Skills

• Strategic Judgment
• Project Management
• Communication Skills
• Leadership

Benefits

• Comprehensive package of benefits including paid time off (vacation, holidays, sick), medical/dental/vision insurance and 401(k).
• This job is eligible to participate in our long-term incentive programs.

Pay

$182,000 - $346,000 USD

Schedule

Hybrid